. .

. ,

.., .., .., .., .., .., .., .., ..
,

, . : , . , , . , IV (2016). , , , , . , , , . . . .

: , , , , , .

, 161 . 13 , 27 [1]. 20 % [2,3,4]. 2,5 23 % [5]. , . , , , / , , , , .

(). 85 % . , () (). .

, . , , [1,5]. , .

. , .

. , . , , . .

[1]. , ( 4), ( 4-7), ( 7) . (). . , , , . , , , [6,7]. , , , [6]. (, , ), , , , - - , [6].

. [8]. 4,0 [5]. , () [9]. , , [1,9]. , [1,9]. , , , , , (), , , , [3,10,11], [12,13].

, - [2,5]. , , () [2,5]. , , [5].

ex juvantibus (), . 1620 % . , 50% , , 12 [1,11]. , / ( ) [14]. , , , , , , , , , , , [1,10,11,15]. (, ). . , , , , , [14]. , [4], (-pH-) .

. ().

, . , 70% . , 2 5 - , 46%. 60% , [15,16]. IV, 40% . 36% , 24% - [6,17].

 

, , 25 % [15]. , , IV . . [6,17]. , , . 5,3 % , 3,94,2 %. . IV, ( ) , , (, , , , ) [6,17,18]. . , (TRPV1), , 1 [18]. , , [17]. : ; , ; , , , , , , , ( - , -, , ). , ex juvantibus c [15]. 2 , 3 6 . , 68 2030 % , . , , , (), , , [6,17].

. . . , , . , (, ). , (, ). 4 , 8 .

- . .

1. Sifrim D., Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors// Gut.2012. Vol. 61. 9. .1340-54.

2. .., .., .. XXI / .. , .. , .. // . . 2015. . 2. 15. . 42-47.

3. .. ( I). , /.. // -. 2014. - 1- 2. .2-14.

4. .., .., .. ( XVII , 1012 2017 ) / .. , .. , .. // , , . 2012. 5. .13-23.

5. .. : , , . / .. // - . . 2006. C. 96103.

6. Aziz Q., Fass R., Gyawali C.P., Miwa H., Pandolfino J.E., Zerbib F. Functional Esophageal Disorders //Gastroenterology. 2016. Vol. 150. .1368-1379.

7. Malfertheiner P., Megraud F., O'Morain C.A. et al. Management of Helicobacter pylori infection - the Maastricht IV. Florence Consensus Report // Gut. 2012. Vol. 61. . 646-664.

8. Sharma N., Agrawal A., Freeman J. et al. An analysis of persistent symptoms in acidsuppressed patients undergoing impedance-pH monitoring // Clin Gastroenterol Hepatol. 2008. Vol.6. .521-524.

9. Fass R., Sifrim D. Management of heartburn not responding to proton pump inhibitors //Gut. 2009. Vol. 58. .295-309.

10. Farre R., Van Malenstein M.H., de Vos R. Weakly acidic solutions containing pepsin and bile acids can increase significantly esophageal mucosa permeability //Gastroenterology. 2007. Vol. 132. 4 (2). P.1897.

11. .., .. , . // .-2015.- 8.- . 1821.

12. . // .. , .. , .. , .. , .. , .. , .. , .. , .. , .. , .. , .. , .. // . 2014. 23 .

13. .. / .. . .: , 2010. 1072 .

14. .., .., .. , - ( ) / .. , .. , .. // . - 2016.- 1 (1). .19-24.

15. .., .., .. / .. , .. , .. // . 2016. .1,2. .167-171.

16. Penagini R., Sweis R., Mauro A., Domingues G., Vales A., Daniel Sifrim D. Inconsistency in the diagnosis of functional heartburn: usefulness of prolonged wireless pH monitoring in patients with proton pump inhibitor refractory gastroesophageal reflux disease//J. Neurogastroenterol. Motil.2015. Vol.21. No. 2. P. 265-272.

17. Drossman D.A. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV //Gastroenterology. 2016. Vol. 150. P. 12621279.

18. Yoshida N., Kuroda M., Suzuki T., Kamada K., Uchiyama K., Handa O. et al.Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease//Dig. Dis. Sci.2013. Vol.58. P. 2237-2243.

http://www.gastroscan.ru